Engel-Nitz NM - Search Results

1

Differences in treatment patterns among patients with castration-resistant prostate cancer treated by oncologists versus urologists in a US managed care population.

Engel-Nitz NM, Alemayehu B, Parry D, Nathan F. Engel-Nitz NM, et al. Cancer Manag Res. 2011;3:233-45. doi: 10.2147/CMR.S21033. Epub 2011 Jul 4. Cancer Manag Res. 2011. PMID: 21792332 Free PMC article.

2

Costs and outcomes of noncardioembolic ischemic stroke in a managed care population.

Engel-Nitz NM, Sander SD, Harley C, Rey GG, Shah H. Engel-Nitz NM, et al. Vasc Health Risk Manag. 2010 Oct 5;6:905-13. doi: 10.2147/VHRM.S10851. Vasc Health Risk Manag. 2010. PMID: 20957133 Free PMC article.

3

Increasing prevalence of metastatic castration-resistant prostate cancer in a managed care population in the United States.

Wallace KL, Landsteiner A, Bunner SH, Engel-Nitz NM, Luckenbaugh AN. Wallace KL, et al. Among authors: engel nitz nm. Cancer Causes Control. 2021 Dec;32(12):1365-1374. doi: 10.1007/s10552-021-01484-4. Epub 2021 Aug 12. Cancer Causes Control. 2021. PMID: 34386852

4

Diagnostic testing managed by hematopathology specialty and other laboratories: costs and patient diagnostic outcomes.

Engel-Nitz NM, Eckert B, Song R, Koka P, Hulbert EM, McPheeters J, Teitelbaum A. Engel-Nitz NM, et al. BMC Clin Pathol. 2014 Apr 27;14:17. doi: 10.1186/1472-6890-14-17. eCollection 2014. BMC Clin Pathol. 2014. PMID: 24817828 Free PMC article.

5

Service setting impact on costs for bevacizumab-treated oncology patients.

Engel-Nitz NM, Yu EB, Becker LK, Small A. Engel-Nitz NM, et al. Am J Manag Care. 2014 Nov 1;20(11):e515-22. Am J Manag Care. 2014. PMID: 25730350 Free article.

6

Costs and mortality of recurrent versus de novo hormone receptor-positive/HER2(-) metastatic breast cancer.

Engel-Nitz NM, Hao Y, Becker LK, Gerdes R. Engel-Nitz NM, et al. J Comp Eff Res. 2015 Aug;4(4):303-14. doi: 10.2217/cer.15.19. J Comp Eff Res. 2015. PMID: 26274792 Free article.

7

The Impact of Adverse Events on Health Care Resource Utilization, Costs, and Mortality Among Patients Treated with Immune Checkpoint Inhibitors.

George S, Bell EJ, Zheng Y, Kim R, White J, Devgan G, Smith J, Lal LS, Engel-Nitz NM, Liu FX. George S, et al. Among authors: engel nitz nm. Oncologist. 2021 Jul;26(7):e1205-e1215. doi: 10.1002/onco.13812. Epub 2021 May 29. Oncologist. 2021. PMID: 33955118 Free PMC article.

8

HER2-Mutant Advanced and/or Metastatic Non-Small-Cell Lung Cancer: A US Electronic Health Records Database Analysis of Clinical Characteristics, Treatment Practice Patterns, and Outcomes.

Waliany S, Neal JW, Engel-Nitz N, Lam C, Lin F, Park L, Le L, Nagasaka M. Waliany S, et al. Clin Lung Cancer. 2024 Jun;25(4):319-328.e1. doi: 10.1016/j.cllc.2024.01.002. Epub 2024 Jan 18. Clin Lung Cancer. 2024. PMID: 38403548 Free article.

9

Cardiovascular events and insulin therapy: a retrospective cohort analysis.

Engel-Nitz NM, Martin S, Sun P, Buesching D, Fonseca V. Engel-Nitz NM, et al. Diabetes Res Clin Pract. 2008 Jul;81(1):97-104. doi: 10.1016/j.diabres.2008.02.011. Epub 2008 Apr 15. Diabetes Res Clin Pract. 2008. PMID: 18417242

10

Antihypertensive medication changes and blood pressure goal achievement in a managed care population.

Engel-Nitz NM, Darkow T, Lau H. Engel-Nitz NM, et al. J Hum Hypertens. 2010 Oct;24(10):659-68. doi: 10.1038/jhh.2010.2. Epub 2010 Jan 28. J Hum Hypertens. 2010. PMID: 20107489

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters